Implantation in the eye of the port delivery system loaded with a bolus of the antivascular endothelial growth factor ranibizumab was associated with similar improvements in visual acuity after 2 ...
Continuous administration of ranibizumab with a port delivery system provides an alternative to frequent intravitreal injections for diabetic macular edema and helps delay progression of ...